Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs medroxyprogesterone acetate for pelvic pain and recurrent endometriosis
IRCT20170917036227N5Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Dec 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dienogest and medroxyprogesterone acetate in endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoint: Pelvic pain improvement. Started Dec 2020; status: completed.
02
Drugs
dienogestmedroxyprogesterone acetate
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20170917036227N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170917036227N5.